Prostate cancer (PCa) is the most common noncutaneous malignancy in men and the
second leading cause of cancer related death in the United States. Men with clinical …

At the turn of the millennium, the role of imaging in prostate cancer was limited to ultrasound‐
guided biopsies, CT, and occasionally MRI for staging the pelvis and bone scanning to …

Imaging plays an increasingly important role in the detection and characterization of prostate
cancer (PC). This review summarizes the key conventional and advanced imaging …

Several advances in the imaging of PCa have been made during the past year. In particular,
important clinical developments have been reported in multiparametric MRI, PET/computed …

Background Diagnosis and treatment of primary prostate cancer (PCA) have undergone
significant changes in the last few years due to modern imaging. Objectives Established and …

Conventional prostate cancer staging strategies have limited accuracy to define the location,
grade, and burden of disease. Evaluations have historically relied upon prostate-specific …

Imaging is critically important for the diagnosis, staging, and management of men with high-
risk prostate cancer. Conventional imaging modalities have been employed for local and …

Prostate cancer is the most common noncutaneous cancer affecting men today. It largely
affects men in the fifth and sixth decade of life. Screening for prostate cancer, though …

Imaging is becoming critical for guiding management decisions in prostate cancer (PCa)
both at initial diagnosis and at recurrence. Multiparametric magnetic resonance imaging …

No consensus exists at present regarding the use of imaging for the evaluation of prostate
cancer. Ultrasonography is mainly used for biopsy guidance and magnetic resonance …